Today: 9 June 2026
Li Auto stock in focus after December deliveries; traders eye Nio, XPeng and Tesla next
1 January 2026
2 mins read

Li Auto stock in focus after December deliveries; traders eye Nio, XPeng and Tesla next

NEW YORK, January 1, 2026, 03:16 ET — Market closed

  • Li Auto said it delivered 44,246 vehicles in December; fourth-quarter deliveries were 109,194.
  • The U.S.-listed stock last closed down about 2% at $16.93; U.S. markets are shut for New Year’s Day.
  • Investors are parsing fresh delivery updates from Chinese EV peers and waiting for Tesla’s quarterly report on Friday.

Li Auto Inc (2015.HK) (LI.O) said late Wednesday it delivered 44,246 vehicles in December, as Chinese electric-vehicle makers begin publishing year-end sales tallies.

Li Auto’s U.S.-listed shares last closed down 34 cents, or about 2%, at $16.93. U.S. equity markets are closed on Thursday for New Year’s Day, with trading set to resume on Friday.

The monthly delivery prints matter because they are one of the earliest reads on demand, and deliveries often map quickly into near-term revenue in the auto business. They also give investors a timely window into how aggressive competition is getting on price and product mix.

For Li Auto, the numbers land at a moment when investors are watching whether the company’s product cadence and overseas push can broaden growth after a volatile year for China’s U.S.-listed EV names. With U.S. markets shut, the first chance for U.S. traders to reprice the update will come when the next session opens.

Li Auto said its fourth-quarter deliveries totaled 109,194 vehicles, and cumulative deliveries reached 1,540,215 as of Dec. 31, clearing the 1.5 million milestone.

The company said it introduced its Li L9, Li L7 and Li L6 models to Egypt, Kazakhstan and Azerbaijan and launched “Li AI glasses, Livis,” in December. Stock Titan

Li Auto bills itself as a pioneer in extended-range electric vehicles — a plug-in setup that runs on batteries but uses a small gasoline engine to generate electricity when the battery runs low. It said it is also building platforms for battery-only EVs in parallel.

Peers posted mixed-looking year-end signals. Nio said it delivered 48,135 vehicles in December, up 54.6% from a year earlier, while XPeng said it delivered 37,508 vehicles, up 2% year-on-year.

Global EV demand remains a moving target, with investors also watching for signals from the U.S. market leader. “The fall will be driven largely by sales in North America and Europe,” Deutsche Bank analyst Edison Yu wrote in a Tesla note, ahead of Tesla’s quarterly deliveries report due Friday. Reuters

In the final U.S. session of 2025, major indexes slipped, with the Nasdaq down 0.76% and the S&P 500 down 0.74% in thin holiday trading, Reuters reported.

Before the next U.S. session opens on Friday, traders will be watching whether the delivery data prompts fresh revisions to near-term expectations — including any read-through to first-quarter demand, when China’s auto market typically faces seasonality. They will also watch for any follow-on company commentary on overseas rollout pace and infrastructure buildout.

Li Auto’s fourth-quarter deliveries landed within the company’s previously stated forecast range of 100,000 to 110,000 vehicles. The next major checkpoint will be its quarterly results and any updated margin outlook, as investors weigh whether volume can stabilize profitability.

Stock Market Today

  • AT&T Shares Rise Pre-Market on $45 Billion Payout Plan, Satellite Broadband Risks Loom
    June 9, 2026, 9:40 AM EDT. AT&T shares edged up 0.36% pre-market to $22.58 ahead of CFO Pascal Desroches' remarks at the Mizuho Technology Conference. The telecom giant reaffirmed its 2026 outlook and plans to return $45 billion to shareholders from 2026 to 2028 through dividends and buybacks. The company forecasted second-quarter free cash flow between $4 billion and $4.5 billion, critical for debt reduction and capital returns. However, investor concern persists over competition from satellite broadband providers like SpaceX's Starlink, which could disrupt traditional telecom revenues. AT&T aims to rebound net debt-to-adjusted EBITDA to around 2.5 times within three years after closing its EchoStar acquisition. Market futures indicated gains ahead of AT&T's July 22 earnings release, despite ongoing sector pressures from emerging satellite services.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Why FICO Stock Is Sliding Today: Fair Isaac Drops in Thin Year-End Trading
Previous Story

Why FICO Stock Is Sliding Today: Fair Isaac Drops in Thin Year-End Trading

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop